Skip Nav Destination
Issues
Review
Perspectives
The Biology Behind
Featured Articles
Clinical Trials
Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients
I. Jolanda M. de Vries; W. Joost Lesterhuis; Nicole M. Scharenborg; Linda P. H. Engelen; Dirk J. Ruiter; Marie-Jeanne P. Gerritsen; Sandra Croockewit; Cedrik M. Britten; Ruurd Torensma; Gosse J. Adema; Carl G. Figdor; Cornelis J. A. Punt
A Phase I Study of SR-4554 via Intravenous Administration for Noninvasive Investigation of Tumor Hypoxia by Magnetic Resonance Spectroscopy in Patients with Malignancy
Beatrice M. Seddon; Geoffrey S. Payne; Laura Simmons; Ruth Ruddle; Rachel Grimshaw; Siew Tan; Alison Turner; Florence Raynaud; Gavin Halbert; Martin O. Leach; Ian Judson; Paul Workman
Molecular Oncology, Markers, Clinical Correlates
Prediction of Nodal Metastasis by Comparative Genomic Hybridization in Biopsy Specimens from Patients with Superficial Esophageal Squamous Cell Carcinoma
Takashi Ueno; Akira Tangoku; Shigefumi Yoshino; Toshihiro Abe; Hideto Hayashi; Hiroaki Toshimitsu; Kiichiro Hashimoto; Tomomitsu Satoh; Atsunori Oga; Tomoko Furuya; Masaaki Oka; Kohsuke Sasaki
Experimental Therapeutics, Preclinical Pharmacology
Regular Articles
Clinical Trials
Phase I Clinical Trial and Pharmacokinetic Study of the Spicamycin Analog KRN5500 Administered as a 1-Hour Intravenous Infusion for Five Consecutive Days to Patients with Refractory Solid Tumors
Jeffrey G. Supko; Joseph P. Eder, Jr.; David P. Ryan; Michael V. Seiden; Thomas J. Lynch; Phillip C. Amrein; Donald W. Kufe; Jeffrey W. Clark
Vaccinia-Expressed Human Papillomavirus 16 and 18 E6 and E7 as a Therapeutic Vaccination for Vulval and Vaginal Intraepithelial Neoplasia
Peter J. Baldwin; Sjoerd H. van der Burg; Christopher M. Boswell; Rienk Offringa; Julian K. Hickling; Jennifer Dobson; John St. Clair Roberts; John A. Latimer; Robin P. Moseley; Nicholas Coleman; Margaret A. Stanley; Jane C. Sterling
Consistent Antibody Response against Ganglioside GD2 Induced in Patients with Melanoma by a GD2 Lactone-Keyhole Limpet Hemocyanin Conjugate Vaccine plus Immunological Adjuvant QS-21
Govind Ragupathi; Philip O. Livingston; Chandra Hood; John Gathuru; Susan E. Krown; Paul B. Chapman; Jedd D. Wolchok; Linda J. Williams; Roberta C. Oldfield; Wen-Jen Hwu
Phase I and Pharmacokinetic Trial of the Novel Taxane BMS-184476 Administered as a 1-Hour Intravenous Infusion in Combination with Cisplatin Every 21 Days
Weijing Sun; James P. Stevenson; Maryann L. Gallagher; David Vaughn; Steven M. Hahn; Daniel G. Haller; Marvin Cohen; Justin Kopit; Gilles Gallant; Peter J. O’Dwyer
Pilot Study of Flt3 Ligand Comparing Intraperitoneal with Subcutaneous Routes on Hematologic and Immunologic Responses in Patients with Peritoneal Carcinomatosis and Mesotheliomas
Ralph S. Freedman; Saroj Vadhan-Raj; Cherie Butts; Cherylyn Savary; Bohuslav Melichar; Claire Verschraegen; John J. Kavanagh; Marshall E. Hicks; Lawrence B. Levy; Jody K. Folloder; Michael E. Garcia
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Interferon Can Block Telomere Erosion and in Rare Cases Result in Hepatocellular Carcinoma Development with Telomeric Repeat Binding Factor 1 Overexpression in Chronic Hepatitis C
Masato Igarashi; Takeshi Suda; Hidenori Hara; Mitsuhiro Takimoto; Minoru Nomoto; Toru Takahashi; Shogo Okoshi; Hirokazu Kawai; Yusaku Mita; Nobuo Waguri; Yutaka Aoyagi
Hypermethylation of O6-Methylguanine-DNA Methyltransferase Promoter May Predict Nonrecurrence after Chemotherapy in Colorectal Cancer Cases
Takeshi Nagasaka; Gerald B. Sharp; Kenji Notohara; Takeshi Kambara; Hiromi Sasamoto; Hiroshi Isozaki; Donald G. MacPhee; Jeremy R. Jass; Noriaki Tanaka; Nagahide Matsubara
Flt-4-Positive Vessel Density Correlates with Vascular Endothelial Growth Factor-D Expression, Nodal Status, and Prognosis in Breast Cancer
Yasushi Nakamura; Hironao Yasuoka; Masahiko Tsujimoto; Qifeng Yang; Shigeru Imabun; Masaaki Nakahara; Kazuyasu Nakao; Misa Nakamura; Ichiro Mori; Kennichi Kakudo
Frequent Loss of Expression of the Cyclin-Dependent Kinase Inhibitor p27Kip1 in Estrogen-Related Endometrial Adenocarcinomas
Valeria Masciullo; Tommaso Susini; Alessandra Zamparelli; Alessandro Bovicelli; Corrado Minimo; Daniela Massi; Gianluigi Taddei; Nicola Maggiano; Pierandrea De Iaco; Marcello Ceccaroni; Luciano Bovicelli; Gianni Amunni; Salvatore Mancuso; Giovanni Scambia; Antonio Giordano
Identification of Patients with Transitional Cell Carcinoma of the Bladder Overexpressing ErbB2, ErbB3, or Specific ErbB4 Isoforms: Real-Time Reverse Transcription-PCR Analysis in Estimation of ErbB Receptor Status from Cancer Patients
Teemu T. Junttila; Matti Laato; Tero Vahlberg; Karl-Ove Söderström; Tapio Visakorpi; Jorma Isola; Klaus Elenius
Experimental Therapeutics, Preclinical Pharmacology
Systemic Administration of GPI 15427, a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, Increases the Antitumor Activity of Temozolomide against Intracranial Melanoma, Glioma, Lymphoma
Lucio Tentori; Carlo Leonetti; Marco Scarsella; Giulia d’Amati; Matteo Vergati; Ilaria Portarena; Weizheng Xu; Vincent Kalish; Gabriella Zupi; Jie Zhang; Grazia Graziani
Identification of Naturally Processed Helper T-Cell Epitopes from Prostate-Specific Membrane Antigen Using Peptide-Based in Vitro Stimulation
Hiroya Kobayashi; Ryusuke Omiya; Benjamin Sodey; Mitsuru Yanai; Kensuke Oikawa; Keisuke Sato; Shoji Kimura; Satoru Senju; Yasuharu Nishimura; Masatoshi Tateno; Esteban Celis
Inhibition of Cyclooxygenase-2 Indirectly Potentiates Antitumor Effects of Photodynamic Therapy in Mice
Marcin Makowski; Tomasz Grzela; Justyna Niderla; Maciej Łazarczyk; Paweł Mróz; Maciej Kopeé; Magdalena Legat; Katarzyna Strusińska; Katarzyna Koziak; Dominika Nowis; Piotr Mrówka; Maria Wąsik; Marek Jakóbisiak; Jakub Gołąb
Letters to the Editor
Correspondence re: M. Provencio, et al. The Topoisomerase IIa Expression Correlates with Survival in Patients with Advanced Hodgkin’s Lymphoma. Clin. Cancer Res., 9: 1406–1411, 2003.
Theodoros P. Vassilakopoulos; Maria K. Angelopoulou; Marina P. Siakantaris; Gerassimos A. Pangalis; Christos Kittas; Ipatia Doussis-Anagnostopoulou
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.